國際簡稱:Cancer Inform 參考譯名:癌癥信息學
主要研究方向:Medicine-Oncology 非預(yù)警期刊 審稿周期: 8 Weeks
《癌癥信息學》(Cancer Informatics)是一本由Libertas Academica出版的以Medicine-Oncology為研究特色的國際期刊,發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評論文章和綜述文章,及時報道該領(lǐng)域相關(guān)理論、實踐和應(yīng)用學科的最新發(fā)現(xiàn),旨在促進該學科領(lǐng)域科學信息的快速交流。該期刊是一本開放期刊,近三年沒有被列入預(yù)警名單。
Cancer Informatics is an academic journal dedicated to the field of cancer informatics. Cancer informatics is an interdisciplinary field that involves multiple disciplines such as biology, computer science, statistics, engineering, etc. It aims to study and solve cancer problems through big data analysis and computational methods. This journal provides a platform for researchers to exchange and share the latest research findings, methods, and technologies to promote the development and application of cancer informatics. The main content of the magazine covers various aspects of cancer informatics, including the analysis and integration of multi omics data such as genomics, proteomics, transcriptomics, metabolomics, and imaging; Discovery and validation of cancer biomarkers; Computational models and algorithms for cancer risk assessment, early diagnosis, prognosis prediction, and treatment response evaluation; And applied research in fields such as precision medicine for cancer, personalized treatment, and drug development.
CiteScore | SJR | SNIP | CiteScore 指數(shù) | ||||||||||||
3 | 0.534 | 0.617 |
|
名詞解釋:CiteScore 是衡量期刊所發(fā)表文獻的平均受引用次數(shù),是在 Scopus 中衡量期刊影響力的另一個指標。當年CiteScore 的計算依據(jù)是期刊最近4年(含計算年度)的被引次數(shù)除以該期刊近四年發(fā)表的文獻數(shù)。例如,2022年的 CiteScore 計算方法為:2022年的 CiteScore =2019-2022年收到的對2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻數(shù)量 注:文獻類型包括:文章、評論、會議論文、書籍章節(jié)和數(shù)據(jù)論文。
按JIF指標學科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學科:MATHEMATICAL & COMPUTATIONAL BIOLOGY | ESCI | Q2 | 24 / 65 |
63.8% |
學科:ONCOLOGY | ESCI | Q3 | 193 / 322 |
40.2% |
按JCI指標學科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學科:MATHEMATICAL & COMPUTATIONAL BIOLOGY | ESCI | Q3 | 46 / 65 |
30% |
學科:ONCOLOGY | ESCI | Q3 | 196 / 322 |
39.29% |